Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) President Warren Hosseinion purchased 252 shares of the company’s stock in a transaction dated Thursday, March 19th. The shares were acquired at an average cost of $94.07 per share, for a total transaction of $23,705.64. Following the transaction, the president owned 7,765 shares of the company’s stock, valued at $730,453.55. This trade represents a 3.35% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Nutex Health Stock Up 6.5%
Shares of NUTX traded up $5.78 on Monday, hitting $94.77. The company’s stock had a trading volume of 141,962 shares, compared to its average volume of 205,966. The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.70. The firm’s fifty day moving average price is $120.56 and its 200-day moving average price is $125.28. Nutex Health Inc. has a fifty-two week low of $45.88 and a fifty-two week high of $193.07. The firm has a market capitalization of $660.54 million, a price-to-earnings ratio of 10.54 and a beta of 0.04.
Nutex Health (NASDAQ:NUTX – Get Free Report) last posted its earnings results on Thursday, March 5th. The company reported $1.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). Nutex Health had a return on equity of 17.67% and a net margin of 7.34%.The business had revenue of $151.68 million for the quarter, compared to the consensus estimate of $258.82 million.
Hedge Funds Weigh In On Nutex Health
Analysts Set New Price Targets
A number of brokerages recently commented on NUTX. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Saturday, March 7th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Nutex Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.
View Our Latest Stock Report on Nutex Health
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Featured Articles
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
